In today’s briefing:
- The Beat Ideas- Patel Engineering: Turnaround Play?
- Interglobe Aviation : Block Deal Trade Special Situations and Tactical Trade Strategy
- Suzlon Independent Director Resignation Raises Concerns and Reiterates Past CG Issues
- Concord Biotech Ltd (CONCORDB IN): Accelerated Growth Ahead; Recent Pullback Comforted Valuation
The Beat Ideas- Patel Engineering: Turnaround Play?
- Patel Engineering (PEC IN) ‘s large order book, strategic sectors focus, and successful debt reduction through QIP and restructuring.
- Strong financial resilience, projected revenue growth, and robust order pipeline signal promising future prospects.
- Poised for growth strong order pipeline and increased government focus on Infrastructure, Hydro Power segment and Irrigation segment.
Interglobe Aviation : Block Deal Trade Special Situations and Tactical Trade Strategy
- Impending block deals which generally create supply over-hang on the stock leads to a negative impact on the stock.
- These block deals generally include selling promoters and big funds at a price discount to its current market price.
- Historically, such events suggest once the block deal is done; stock reacts positively creating a Special Situation Opportunity
Suzlon Independent Director Resignation Raises Concerns and Reiterates Past CG Issues
- Independent Director’s resignation highlights the lack of strong corporate governance practices within Suzlon.
- Suzlon Energy’s response to the outgoing director’s concerns demonstrates a willingness to address issues and make necessary changes to enhance corporate governance.
- Though it does not raise concerns on any financial irregularities and legal violation but resolution of issues remains a key event to watch for.
Concord Biotech Ltd (CONCORDB IN): Accelerated Growth Ahead; Recent Pullback Comforted Valuation
- Concord Biotech Ltd (CONCORDB IN) reported 19% revenue growth in FY24. EBITDA and PAT grew at a faster pace of 26% and 28%, YoY, respectively.
- With focus on deeper market penetration, acquiring new customers, and introducing new products in niche categories, Concord is well-positioned for 25% revenue CAGR in 3–5 years.
- Despite a huge run-up from the IPO price, Concord shares are trading at forward P/E of 38.9x, which is lower than peers.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
